Skip to main page content

Dr. Wai-Ching Lam

Scientific Planning Committee - Co-Developed Symposium
Participates in 5 items

Dr. Wai-Ching Lam is the Head of the Ophthalmology Department of Vancouver General Hospital, and the Medical Director of Ophthalmology of the UBC Hospital

Dr. Lam is a vitreo-retinal surgeon with clinical interests in adult and pediatric retinal diseases. For his clinical and scientific work, he received the Achievement Award from the American Academy of Ophthalmology and Asian Pacific Academy of Ophthalmology, and Fellow and the Senior Honor Award from the American Society of Retinal Specialists. 

He is a committed medical educator and won 16 teaching awards in 18 years from the Faculty of Medicine and the Department of Surgery, and Ophthalmology and Vision Sciences while at the University of Toronto. 

He has published over 100 peer-reviewed articles. He has also authored 7 book chapters, and recently co-edit a new book, “A Quick Guide Pediatric Retina”, Springer 2021. 

Financial disclosure: Dr. Lam has/had an affiliation (financial or otherwise) with a commercial organization:

  1. Alcon
  2. Allergan
  3. Bayer
  4. Novartis
  5. Roche

 

Sessions in which Dr. Wai-Ching Lam participates

Friday 16 June, 2023

Time Zone: (GMT-05:00) Eastern Time (US & Canada)

Saturday 17 June, 2023

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
6:30 AM
6:30 AM - 8:00 AM | 1 hour 30 minutes
Co-Developed Symposium

*Breakfast to be served from 6:00am* Learning Objectives: At the end of this session, participants will be able to: Outline the role of the Tie-2/ang pathway in DR and nAMDand how it may impact patient outcomesIdentify the most important biomarkerson structural OCT that can help predict treatmentresponse in DME and nAMDDiscuss r...

7:10 AM